The UK’s 100,000 Genomes Project has revealed that certain tumors are more likely to carry mutations that can inform patient care, steering treatment choices or indicating a potential familial risk. The findings from over 13,800 solid tumors in adults are already influencing clinical practice in the UK’s National Health Service, with patients diagnosed with certain types of brain cancers, sarcomas, and ovarian cancers now receiving sequencing of their tumors as a standard part of their care. This demonstrates how genetics research can have a direct impact on patient treatment and care, showing the potential of personalized medicine in the future.
Source link
U.K. sequencing study surfaces new findings about tumor DNA
